Schistosoma Haematobium Infections and Praziquantel

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Khartoum
• Collaborator: Hikma Pharmaceuticals LLC
• Treatments: Praziquantel

Criteria

Inclusion Criteria:

• School children

Exclusion Criteria:

• Taking praziquantel